Paradeep Phosphates Ltd
Paradeep Phosphates Ltd Q1 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book
Q1 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Paradeep Phosphates Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Revenue from Operations for Q1 FY25 was Rs. EBITDA for Q1 FY25: Rs.
From Paradeep Phosphates Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Revenue from Operations for Q1 FY25 was Rs. 23,774 million, down 22.2% YoY (Page 11).
- Total Income for Q1 FY25 was Rs. 23,966 million, down 22.0% YoY (Page 11).
- Manufactured sales volumes for Q1 FY25:
- Total fertilizers: 554,571 MT, down 11% YoY (Page 7).
- NPK: 115,531 MT, up 28% YoY (Page 7).
- DAP: 102,918 MT, down 64% YoY (Page 7).
- Urea: 108,619 MT (Page 7).
- Production volumes for Q1 FY25:
- Total fertilizers: 539,194 MT, down 16% YoY (Page 6).
- Phosphoric acid up 59% YoY (Page 6).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Paradeep Phosphates Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Expanded phosphoric acid capacity is now operational, resulting in ~60% production increase in Q1 FY25 (Page 9).
- Sulphuric acid production capacity is being increased from 1.4 to 2 MMTPA; project is ongoing (Page 9).
- Four new urea production plants are expected to be operational by 2025, aiding India's drive toward urea self-sufficiency (Atma Nirbhar Bharat) (Page 16).
- No specific capex amounts or detailed timelines for these expansions were mentioned in the presentation.
2 more points management made on capital expenditure plans
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Paradeep Phosphates Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Paradeep Phosphates Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹4.7K Cr, net profit ₹156 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Paradeep Phosphates Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Madhya Bharat Agro Products Ltd (Q1 FY25)
982 crore . Key investor presentation takeaways from Madhya Bharat Agro Products Ltd's Q1 FY25 investor presentation — and how it ranks against sector peers.
- Sumitomo Chemical India Ltd (Q1 FY25)
838.9 Cr, up 16% YoY from Rs. Key investor presentation takeaways from Sumitomo Chemical India Ltd's Q1 FY25 investor presentation — and how it ranks against se
- Heranba Inds (Q1 FY25)
Q1FY25: ₹304.35 crore . Key investor presentation takeaways from Heranba Industries Ltd's Q1 FY25 investor presentation — and how it ranks against sector peers.
- Dharmaj Crop (Q1 FY25)
Revenue from Operations for Q1FY25: ₹2,553 million, a 62% year-on-year (YoY) increase from ₹1,575 million in Q1FY24. Key investor presentation takeaways from Dh
Frequently Asked Questions
What were Paradeep Phosphates Ltd Q1 FY25 results?
Revenue from Operations for Q1 FY25 was Rs. EBITDA for Q1 FY25: Rs.
What is Paradeep Phosphates Ltd share price analysis?
Paradeep Phosphates Ltd currently shows a neutral. The stock trades at a P/E of 14.9 with a market cap of ₹16,161 Cr. Investors should review the full earnings analysis for detailed insights.
Is Paradeep Phosphates Ltd planning capital expenditure?
Expanded phosphoric acid capacity is now operational, resulting in ~60% production increase in Q1 FY25 (Page 9).
Keep Paradeep Phosphates Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
